RELX PLC's stock has fallen 3.02% and hit a 52-week low amid broader market declines, with the Nasdaq-100 down 1.11% and the S&P 500 down 0.74%.
The decline in RELX's stock price occurs despite LexisNexis Risk Solutions achieving FedRAMP 'In Process' status, which indicates the company is undergoing rigorous security assessments to enhance its compliance and security in handling federal data. This milestone reflects the company's commitment to meeting the highest security standards and solidifies its trust with federal partners, enhancing its competitive position in the government technology solutions market.
The implications of this achievement are significant for RELX, as it not only enhances LexisNexis's market reputation but also demonstrates its operational excellence in government projects, potentially leading to increased opportunities in the public sector.
Wall Street analysts forecast RELX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RELX is 60.54 USD with a low forecast of 60.54 USD and a high forecast of 60.54 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast RELX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RELX is 60.54 USD with a low forecast of 60.54 USD and a high forecast of 60.54 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 37.380
Low
60.54
Averages
60.54
High
60.54
Current: 37.380
Low
60.54
Averages
60.54
High
60.54
JPMorgan
Daniel Kerven
maintain
2025-12-10
Reason
JPMorgan
Daniel Kerven
Price Target
AI Analysis
2025-12-10
maintain
Reason
JPMorgan analyst Daniel Kerven raised the firm's price target on Relx to 5,070 GBp from 4,920 GBp and keeps an Overweight rating on the shares.
Deutsche Bank
Hold
to
Buy
upgrade
2025-12-09
Reason
Deutsche Bank
Price Target
2025-12-09
upgrade
Hold
to
Buy
Reason
As previously reported, Deutsche Bank upgraded Relx to Buy from Hold with a price target of 3,700 GBp, down from 4,072 GBp. The firm believes the recent de-rating of the shares provides an attractive entry point. Relx is a "high-quality, deep data,very well-invested technology business" with attractive organic growth and increasing margins, the analyst tells investors in a research note. The firm attributes the stock's selloff to results at peers and concerns over artificial intelligence.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for RELX
Unlock Now
Deutsche Bank
Hold
to
Buy
upgrade
£3,700
2025-12-09
Reason
Deutsche Bank
Price Target
£3,700
2025-12-09
upgrade
Hold
to
Buy
Reason
Deutsche Bank upgraded Relx to Buy from Hold with a 3,700 GBp price target.
Kepler Cheuvreux
Conor O'Shea
Hold
to
Buy
upgrade
$3,905
2025-09-18
Reason
Kepler Cheuvreux
Conor O'Shea
Price Target
$3,905
2025-09-18
upgrade
Hold
to
Buy
Reason
Kepler Cheuvreux analyst Conor O'Shea upgraded Relx to Buy from Hold with a 3,905 GBp price target.
About RELX
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
